维普中文期刊产品整合服务

Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks

查看全文 作  者:German [1]G.Gomez;Jill [1]Wykosky;Ciro [1]Zanca;Frank [1]B.Furnari;Webster [1]K.Cavenee 高影响力作者 机构地区:[1]Ludwig Institute for Cancer Research, University of California San Diego高影响力机构 出  处:《Cancer Biology & Medicine》索引2013年第10卷第4期,共14页高影响力期刊 基  金:supported by An American Brain Tumor Association Basic Research grant to G.G.G. in memory of Keith Powers, P01-CA95616, R01-NS080939;James S. McDonnell Foundation 摘  要:Receptor tyrosine kinases(RTKs)such as the epidermal growth factor receptor(EGFR)regulate cellular homeostatic processes.EGFR activates downstream signaling cascades that promote tumor cell survival,proliferation and migration.Dysregulation of EGFR signaling as a consequence of overexpression,amplification and mutation of the EGFR gene occurs frequently in several types of cancers and many become dependent on EGFR signaling to maintain their malignant phenotypes.Consequently,concerted efforts have been mounted to develop therapeutic agents and strategies to effectively inhibit EGFR.However,limited therapeutic benefits to cancer patients have been derived from EGFR-targeted therapies.A well-documented obstacle to improved patient survival is the presence of EGFR-inhibitor resistant tumor cell variants within heterogeneous tumor cell masses.Here,we summarize the mechanisms by which tumors resist EGFR-targeted therapies and highlight the emerging role of microRNAs(miRs)as downstream effector molecules utilized by EGFR to promote tumor initiation,progression and that play a role in resistance to EGFR inhibitors.We also examine evidence supporting the utility of miRs as predictors of response to targeted therapies and novel therapeutic agents to circumvent EGFR-inhibitor resistance mechanisms. 关 键 词:表皮生长因子受体 MICRORNA 治疗药物 癌症患者 信号网络 抗药性 受体抑制剂 受体酪氨酸激酶
相关文献

参考文献(61)

引证文献(3)

耦合文献(25)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费